Gulf Pharmaceutical Industries P.S.C Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Gulf Pharmaceutical Industries P.S.C.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 16.6% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
Improved Revenues Required Before Gulf Pharmaceutical Industries P.S.C. (ADX:JULPHAR) Stock's 26% Jump Looks Justified
Oct 16
Gulf Pharmaceutical Industries P.S.C.'s (ADX:JULPHAR) Share Price Boosted 42% But Its Business Prospects Need A Lift Too
Jan 15Gulf Pharmaceutical Industries P.S.C.'s (ADX:JULPHAR) Price Is Right But Growth Is Lacking
Nov 04Gulf Pharmaceutical Industries P.S.C's (ADX:JULPHAR) Solid Profits Have Weak Fundamentals
Mar 26Gulf Pharmaceutical Industries P.S.C's(ADX:JULPHAR) Share Price Is Down 59% Over The Past Five Years.
Feb 08Here's What Gulf Pharmaceutical Industries P.S.C.'s (ADX:JULPHAR) Shareholder Ownership Structure Looks Like
Dec 14In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Gulf Pharmaceutical Industries P.S.C has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2024 | 1,713 | -25 | 196 | 252 | N/A |
| 6/30/2024 | 1,662 | -58 | 156 | 208 | N/A |
| 3/31/2024 | 1,623 | -98 | 117 | 166 | N/A |
| 12/31/2023 | 1,638 | -104 | 65 | 92 | N/A |
| 9/30/2023 | 1,587 | -128 | -9 | 42 | N/A |
| 6/30/2023 | 1,637 | -85 | -54 | -2 | N/A |
| 3/31/2023 | 1,652 | -38 | -42 | 16 | N/A |
| 12/31/2022 | 1,616 | -34 | -46 | 19 | N/A |
| 9/30/2022 | 1,651 | -28 | -68 | -7 | N/A |
| 6/30/2022 | 1,598 | 0 | 13 | 75 | N/A |
| 3/31/2022 | 1,398 | 64 | 10 | 59 | N/A |
| 12/31/2021 | 1,143 | 47 | 2 | 46 | N/A |
| 9/30/2021 | 858 | -104 | -42 | -21 | N/A |
| 6/30/2021 | 682 | -138 | -117 | -101 | N/A |
| 3/31/2021 | 632 | -203 | -145 | -125 | N/A |
| 12/31/2020 | 573 | -247 | -184 | -168 | N/A |
| 9/30/2020 | 540 | -184 | -238 | -229 | N/A |
| 6/30/2020 | 376 | -377 | -240 | -224 | N/A |
| 3/31/2020 | 295 | -472 | -179 | -159 | N/A |
| 12/31/2019 | 302 | -494 | -119 | -85 | N/A |
| 9/30/2019 | 265 | -957 | 10 | 62 | N/A |
| 6/30/2019 | 388 | -840 | 31 | 84 | N/A |
| 3/31/2019 | 567 | -716 | 87 | 145 | N/A |
| 12/31/2018 | 720 | -612 | 127 | 179 | N/A |
| 9/30/2018 | 928 | -20 | 72 | 136 | N/A |
| 6/30/2018 | 1,106 | 80 | N/A | 200 | N/A |
| 3/31/2018 | 1,085 | 70 | N/A | 113 | N/A |
| 12/31/2017 | 1,155 | 95 | N/A | 81 | N/A |
| 9/30/2017 | 1,293 | 142 | N/A | 234 | N/A |
| 6/30/2017 | 1,275 | 145 | N/A | 234 | N/A |
| 3/31/2017 | 1,418 | 178 | N/A | 264 | N/A |
| 12/31/2016 | 1,455 | 212 | N/A | 268 | N/A |
| 9/30/2016 | 1,391 | 205 | N/A | 261 | N/A |
| 6/30/2016 | 1,407 | 215 | N/A | 242 | N/A |
| 3/31/2016 | 1,391 | 214 | N/A | 235 | N/A |
| 12/31/2015 | 1,470 | 230 | N/A | 183 | N/A |
| 9/30/2015 | 1,510 | 226 | N/A | 117 | N/A |
| 6/30/2015 | 1,449 | 235 | N/A | 161 | N/A |
| 3/31/2015 | 1,443 | 228 | N/A | 96 | N/A |
| 12/31/2014 | 1,388 | 204 | N/A | 40 | N/A |
| 9/30/2014 | 1,382 | 224 | N/A | 131 | N/A |
| 6/30/2014 | 1,427 | 231 | N/A | -22 | N/A |
| 3/31/2014 | 1,425 | 238 | N/A | 79 | N/A |
| 12/31/2013 | 1,362 | 230 | N/A | 108 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if JULPHAR's forecast earnings growth is above the savings rate (14.7%).
Earnings vs Market: Insufficient data to determine if JULPHAR's earnings are forecast to grow faster than the AE market
High Growth Earnings: Insufficient data to determine if JULPHAR's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if JULPHAR's revenue is forecast to grow faster than the AE market.
High Growth Revenue: Insufficient data to determine if JULPHAR's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if JULPHAR's Return on Equity is forecast to be high in 3 years time